Forbes November 28, 2021
Sachin H. Jain

The sun is setting early, the wind is blowing and the fireplace is warmly lit. All of which means it’s time to gather with family, reconnect with old friends, and predict what lies ahead for the healthcare industry.

If you’ve read my annual predictions before, you know that I rarely get everything right. But looking back at last year’s list, I think I did pretty well. (“Biopharma will enjoy a short-lived reputation rebound?”) Did I get other things wrong? Anything that impressed you? I invite you to let me know on Twitter @sacjai.

Before we move on to this year’s list, let me say upfront that it intentionally omits any predictions about COVID-19. That’s because if I’ve learned anything from...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Equity/SDOH, Govt Agencies, Healthcare System, Insurance, Investments, Medicaid, Medicare Advantage, Patient / Consumer, Pharma / Biotech, Physician, Primary care, Provider, Technology, Trends
How the primary care shortage is spilling over into ASCs
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Private equity bankruptcies in healthcare explode 112% in 5 years
How Mercy accelerated rare disease diagnoses in rural areas
Study: Disparities in access to in-network behavioral health care pervasive

Share This Article